Skip to content Home / Companies / PFE PFE
PFIZER INC (PFE) S&P 500 XNYS PHARMACEUTICAL PREPARATIONS Net insider buying (90d)
Latest PFE Insider Trades Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Headquarters NEW YORK, NY
Employees 75,000
Listed 1951
Exchange XNYS https://www.pfizer.com SEC filings for PFE on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market purchase 3 114,863 $2.96M Open-market sale 2 5,278 $135K Grant or award 12 10,700
PFE Insider Transactions (Form 4) 53 111 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Apr 23, 2026 CT Cyrus Taraporevala - Director Grant or award Phantom Stock Units
Recent PFE Form 8-K Filings 5
PFE Insider Trading - FAQ
What is the latest insider trade for PFE? PFIZER INC (PFE) had 17 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for PFE runs to 111 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PFE stock? 3 insider purchases of PFE were filed in the last 90 days, totaling $2.96M.
How many insiders are selling PFE stock? 2 insider sales of PFE were filed in the last 90 days, totaling $135K.
Where can I see PFE SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks PFE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PFE insider buys? Create a free InsiderAlpha account and press Watch on this page to add PFE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track PFE insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free - Director
Open-market purchase $999K
Market cap $159.36B
P/E ratio 36.80
Dividend yield -
Average volume 41.90M
52 week high $28.75
52 week low $23.58
Today's high $28.02
Today's low $27.77
Open $28.00
Volume 27.27M
Previous close $28.02
Shares outstanding 5.70B Market cap
$159.36B
75,000 employees
PFE Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
96% Buying 4% Selling
3 insider purchases totaling $2.96M against 2 sales totaling $135K.
Most-Active PFE Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Apr 15, 2026 AB Albert Bourla - Officer Grant or award Phantom Stock Units SSP 22 $27.19 $598
Apr 14, 2026 AB Albert Bourla - Officer Grant or award Phantom Stock Units SSP 911 $27.11 $25K
Mar 31, 2026 AB Albert Bourla - Officer Grant or award Phantom Stock Units SSP 21 $28.08 $590
Mar 27, 2026 CT Cyrus Taraporevala - Director Grant or award Phantom Stock Units 1,387 $27.04 $37K
Mar 27, 2026 JS James C. Smith - Director Grant or award Phantom Stock Units 1,664 $27.04 $45K
Mar 27, 2026 JQ James Quincey - Director Grant or award Phantom Stock Units 1,433 $27.04 $39K
Mar 27, 2026 SN Shantanu Narayen - Director Grant or award Phantom Stock Units 1,849 $27.04 $50K
Mar 27, 2026 JE Joseph Echevarria - Director Grant or award Phantom Stock Units 1,710 $27.04 $46K
Mar 13, 2026 AB Albert Bourla - Officer Grant or award Phantom Stock Units SSP 1,630 $26.58 $43K
Mar 4, 2026 JD Jennifer B. Damico - Officer Tax withholding / forfeiture Common Stock 826 $26.62 $22K
Mar 3, 2026 JD Jennifer B. Damico - Officer Grant or award Stock Appreciation Rights 22,638 $0.00 -
Mar 3, 2026 AB Albert Bourla - Officer Grant or award Stock Appreciation Rights 708,666 $0.00 -
Mar 3, 2026 DD David M. Denton - Officer Grant or award Stock Appreciation Rights 216,537 $0.00 -
Mar 3, 2026 DL Douglas M. Lankler - Officer Grant or award Stock Appreciation Rights 194,883 $0.00 -
Mar 3, 2026 AM Aamir Malik - Officer Grant or award Stock Appreciation Rights 194,883 $0.00 -
Mar 3, 2026 AB Andrew Baum - Officer Grant or award Stock Appreciation Rights 303,151 $0.00 -
Mar 3, 2026 LF Lidia Fonseca - Officer Grant or award Stock Appreciation Rights 82,284 $0.00 -
Mar 3, 2026 MM Michael McDermott - Officer Grant or award Stock Appreciation Rights 151,576 $0.00 -
Mar 3, 2026 PS Payal Sahni - Officer Grant or award Stock Appreciation Rights 108,268 $0.00 -
Feb 27, 2026 JD Jennifer B. Damico - Officer Tax withholding / forfeiture Common Stock 655 $27.65 $18K
Feb 25, 2026 PS Payal Sahni - Officer Option exercise Stock Appreciation Rights 56,888 $0.00 -
Feb 25, 2026 PS Payal Sahni - Officer Option exercise Common Stock 56,888 $33.82 $1.92M
Feb 25, 2026 PS Payal Sahni - Officer Tax withholding / forfeiture Common Stock 1,083 $27.09 $29K
Feb 25, 2026 PS Payal Sahni - Officer Tax withholding / forfeiture Common Stock 54,066 $26.92 $1.46M
Feb 25, 2026 DL Douglas M. Lankler - Officer Option exercise Stock Appreciation Rights 122,907 $0.00 -
Feb 25, 2026 DL Douglas M. Lankler - Officer Tax withholding / forfeiture Common Stock 2,198 $27.09 $60K
Feb 25, 2026 DL Douglas M. Lankler - Officer Tax withholding / forfeiture Common Stock 116,811 $26.92 $3.14M
Feb 25, 2026 JD Jennifer B. Damico - Officer Option exercise Stock Appreciation Rights 17,558 $0.00 -
Feb 25, 2026 JD Jennifer B. Damico - Officer Tax withholding / forfeiture Common Stock 361 $27.09 $10K
Feb 25, 2026 JD Jennifer B. Damico - Officer Tax withholding / forfeiture Common Stock 16,687 $26.92 $449K
Feb 25, 2026 AB Albert Bourla - Officer Option exercise Stock Appreciation Rights 491,626 $0.00 -
Feb 25, 2026 AB Albert Bourla - Officer Option exercise Common Stock 491,626 $33.82 $16.63M
Feb 25, 2026 AB Albert Bourla - Officer Tax withholding / forfeiture Common Stock 8,303 $27.09 $225K
Feb 25, 2026 AB Albert Bourla - Officer Tax withholding / forfeiture Common Stock 467,241 $26.92 $12.58M
Feb 25, 2026 LF Lidia Fonseca - Officer Option exercise Stock Appreciation Rights 56,888 $0.00 -
Feb 25, 2026 LF Lidia Fonseca - Officer Option exercise Common Stock 56,888 $33.82 $1.92M
Feb 25, 2026 LF Lidia Fonseca - Officer Tax withholding / forfeiture Common Stock 1,058 $27.09 $29K
Feb 25, 2026 LF Lidia Fonseca - Officer Tax withholding / forfeiture Common Stock 54,066 $26.92 $1.46M
Feb 25, 2026 MM Michael McDermott - Officer Option exercise Common Stock 37,925 $33.82 $1.28M
Feb 25, 2026 MM Michael McDermott - Officer Tax withholding / forfeiture Common Stock 679 $27.09 $18K
Feb 25, 2026 MM Michael McDermott - Officer Tax withholding / forfeiture Common Stock 36,044 $26.92 $970K
Feb 26, 2026 MM Michael McDermott - Officer Tax withholding / forfeiture Common Stock 3,503 $27.10 $95K
Feb 25, 2026 MM Michael McDermott - Officer Option exercise Stock Appreciation Rights 37,925 $0.00 -
Feb 25, 2026 CB Christoffel Boshoff - Officer Tax withholding / forfeiture Common Stock 6,833 $27.09 $185K
$IONS
IONIS PHARMACEUTICALS INC
Albert Bourla - OfficerOpen-market purchase$1.00M
Cyrus Taraporevala - Director
